News
7h
CivicScience on MSNGLP-1 Trends by CivicScience: Costs Emerge as a Barrier Amid Uncertainty, But Emotional Wellbeing ImprovesThis is just a tiny glimpse of the data available to CivicScience clients. Discover more data. CivicScience has data on more ...
You may have heard of "Ozempic face" and "Ozempic butt." Well, now there's "Ozempic mouth" and "Ozempic feet" to describe ...
Weightloss drugs can also cause what is known as Ozempic hands. As with the feet and face, these areas show fat loss more ...
Nationally representative survey data reveals that glucagon-like peptide 1 receptor agonists (GLP-1 RAs) use for obesity ...
As weight loss medications, including Ozempic and WeGovy, have gained popularity across the U.S., they are not without side effects, some serious. According to a May 2024 CNN report, as many as 1 in 8 ...
The use of GLP-1s among patients with type 2 diabetes appeared associated with significantly reduced risk for certain ...
With GLP-1 shortage officially over, patients who relied on compounded copies have only bad options to choose from ...
On Friday, the company’s health services unit Evernorth unveiled new programs in a reliable growth area: helping payers ...
Mukhopadhyay took Mounjaro, an antidiabetic medication also used for weight loss, and saw dramatic results—losing 15 percent ...
The rise in GLP-1 use among young women raises concerns about contraceptive efficacy and potential pregnancy risks. Learn ...
Some telehealth companies that offered compounded GLP-1s have disappeared altogether. Others are pursuing strategies that ...
Despite the $1,000-per-dose price tag, GLP-1s may offer long-term ROI by lowering chronic disease rates GLP-1 weight loss ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results